Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy — Sponsor Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

5 Recruiting

2 Completed trials

1 Countries active

21 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 2 Phase II: 7

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Acute coronary syndrome 1 Relapsing-remitting multiple sclerosis 1 Multiple sclerosis 1 Crohn's disease 1

Top IMPs

INOSITOL TRISPYROPHOSPHATE HEXASODIUM 1 L-LYSINE ACETATE, L-TRYPTOPHAN, L-HISTIDINE, L-THREONINE, L-TYROSINE, KETO-ISOLEUCINE CALCIUM, KETO-LEUCINE CALCIUM, KETO-VALINE CALCIUM, HYDROXI-METHIONINE CALCIUM, ALPHA-KETOPHENYLALANINE CALCIUM 1 LACTOBACILLUS HELVETICUS, LACTOBACILLUS RHAMNOSUS, STRAIN LCR35, LIVE 1 OFATUMUMAB 1 OZANIMOD 1 OZANIMOD, OZANIMOD 1 RITUXIMAB 1 SODIUM CHLORIDE 1 TIANEPTINE SODIUM 1

All trials

9 total

PRObiotic Therapy Examining Combinatorial Therapeutics in Multiple Sclerosis - phase II, multicenter, randomised, open-label clinical trial. Not authorised

2025-520955-10-00 Phase II 1 country LACTOBACILLUS HELVETICUS, LACTOBACILLUS RHAMNOSUS, STRAIN LCR35, LIVE; OFATUMUMA…
"MetCool ACS"- Metformin "Cooling" Effect on metformin-naive Patients Treated with PCI because of Acute Coronary Syndrome Pending

2024-516589-13-00 Phase III 1 country
Evaluation of the efficacy and safety of dual biologic and/or small molecule therapy in patients with induction-resistant ulcerative colitis… Recruiting

2023-506628-98-00 Phase II 1 country
Evaluation of the efficacy and safety of dual biological therapy in patients with refractory Crohn's disease resistant to induction (FLAMING… Recruiting

2023-506626-37-00 Phase II 1 country
A randomized trial comparing efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA) Recruiting

2023-506623-29-01 Phase II 1 country
Randomized, double-blind, placebo-controlled trial of the efficacy and safety of tianeptine in the treatment of covid fog symptoms in patien… Recruiting

2024-510790-19-00 Phase II 1 country TIANEPTINE SODIUM
FORMA – a multicentre randomized-controlled trial to evaluate the efficacy and safety of ketoanalogues of essential amino acids in prophylax… Recruiting

2024-517880-22-00 Phase III 1 country L-LYSINE ACETATE, L-TRYPTOPHAN, L-HISTIDINE, L-THREONINE, L-TYROSINE, KETO-ISOLE…
RemiRit - Personalized immunosuppressive therapy with rituximab in the treatment of ANCA associated vasculitis - a randomized, multicenter c… Ended

2024-517881-40-00 Phase II 1 country RITUXIMAB
ITPP as an adjunctive treatment for progressive respiratory failure in COVID-19 and other pulmonary parenchymal infections [BREATH2] Ended

2024-517878-21-00 Phase II 1 country INOSITOL TRISPYROPHOSPHATE HEXASODIUM; SODIUM CHLORIDE

Showing 1–9 of 9 trials

← All sponsors A–Z